Literature DB >> 7885201

[A nosocomial epidemic of Salmonella mbandaka which produces various broad spectrum beta-lactamases: preliminary results].

K Rahal1, A Reghal.   

Abstract

During a nosocomial epidemic of Salmonella mbandaka in Algeria, 99 strains were isolated from specimens. Study of 22 of them revealed minimum inhibiting concentrations ranged from 4 to 32 micrograms/ml for cefotaxime, 2 to 32 micrograms/ml for ceftazidime and 2 to 16 micrograms/ml for ceftriaxione. The mechanism underlying resistance was enzymatic with production of broad-spectrum beta-lactamase enzyme. Clavulinic acid at a dose of 2 micrograms/ml restored the activity of hydrolyzed beta-lactamases. Resistance to all antibiotics including cefotaxime was due to a single plasmid structure. The plasmid did not belong to any known compatibility group. All strains studied contained a plasmid of 26MDa and produced TEM-1 and TEM-2 beta-lactamases. Strains resistant to cefotaxime also synthetized a broad-spectrum beta-lactamase derived from TEM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7885201

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  2 in total

1.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  Prevalence and clonal relationship of ESBL-producing Salmonella strains from humans and poultry in northeastern Algeria.

Authors:  Samia Djeffal; Sofiane Bakour; Bakir Mamache; Rachid Elgroud; Amir Agabou; Selma Chabou; Sana Hireche; Omar Bouaziz; Kheira Rahal; Jean-Marc Rolain
Journal:  BMC Vet Res       Date:  2017-05-15       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.